ConductScience.org, home

Paper25484

Central alpha-adrenergic systems as targets for hypotensive drugs.

Kobinger. Rev Physiol Biochem Pharmacol, 1978. Cited by 522 papers, by iCite.

Cite this record

ConductScience Library. Central alpha-adrenergic systems as targets for hypotensive drugs. Papers, record 25484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25484

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Central alpha-adrenergic systems as targets for hypotensive drugs.
PubMed
Journal
Rev Physiol Biochem Pharmacol
PubMed
Year
1978
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
522
iCite
Relative citation ratio, by iCite
24.7
iCite
Revised in PubMed
2019-10-27
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kobinger

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
Receptors, AdrenergicMajor topic
Receptors, Adrenergic, alphaMajor topic
Adrenergic alpha-Agonists
Adrenergic alpha-Antagonists
Animals
Chemical Phenomena
Chemistry
Clonidine
Depression, Chemical
Hemodynamics
Methyldopa
Norepinephrine

Source PubMed

Download CSV of topics

Cited by101

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 522 citations.

PMIDTitleJournalYearIn PapersSource
42523382Pannexin 1 phosphorylation sites differentially modulate channel activity and physiological outcomes.bioRxiv2026https://conductscience.org/library/papers/42523382PubMed
38123817Combined treatment with naloxone and the alpha2 adrenoceptor antagonist atipamezole reversed brain hypoxia induced by a fentanyl-xylazine mixture in a rat model.Neuropsychopharmacology2024https://conductscience.org/library/papers/38123817PubMed
37490122Clonidine stimulates force of contraction via histamine H2 receptors in the human atrium.Naunyn Schmiedebergs Arch Pharmacol2024https://conductscience.org/library/papers/37490122PubMed
37340247Xylazine effects on opioid-induced brain hypoxia.Psychopharmacology (Berl)2023https://conductscience.org/library/papers/37340247PubMed
35557843Prescribed drugs containing nitrogen heterocycles: an overview.RSC Adv2020https://conductscience.org/library/papers/35557843PubMed
28747467Isoflurane, ketamine-xylazine, and urethane markedly alter breathing even at subtherapeutic doses.J Neurophysiol2017https://conductscience.org/library/papers/28747467PubMed
27895591Comparison in Conscious Rabbits of the Baroreceptor-Heart Rate Reflex Effects of Chronic Treatment with Rilmenidine, Moxonidine, and Clonidine.Front Physiol2016https://conductscience.org/library/papers/27895591PubMed
27517438Neurogenic aspects of essential hypertension in man.Ir J Med Sci1979https://conductscience.org/library/papers/27517438PubMed
27516742Effect of Endothelin-1 on Baroreflexes and the Cardiovascular Action of Clonidine in Conscious Rabbits.Front Physiol2016https://conductscience.org/library/papers/27516742PubMed
24129834Dermal exposure to a compounded pain cream resulting in severely elevated clonidine concentration.J Med Toxicol2014https://conductscience.org/library/papers/24129834PubMed
23497612A comparison of medetomidine and its active enantiomer dexmedetomidine when administered with ketamine in mice.BMC Vet Res2013https://conductscience.org/library/papers/23497612PubMed
19116263Clonidine pharmacokinetics in pregnancy.Drug Metab Dispos2009https://conductscience.org/library/papers/19116263PubMed
18795268S(-)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats.Psychopharmacology (Berl)2009https://conductscience.org/library/papers/18795268PubMed
15278815Does preoperative oral clonidine inhibit salivary secretion during general anesthesia?J Anesth1993https://conductscience.org/library/papers/15278815PubMed
11723356Beyond the usual strategies for blood pressure reduction: therapeutic considerations and combination therapies.J Clin Hypertens (Greenwich)2001https://conductscience.org/library/papers/11723356PubMed
11682443Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation.Br J Pharmacol2001https://conductscience.org/library/papers/11682443PubMed
11470013Do most antihypertensive agents have a sympatholytic action?Curr Hypertens Rep2001https://conductscience.org/library/papers/11470013PubMed
8905472The effects of clonidine on blood pressure, catecholamine and growth hormone release in hypogonadal men is preserved and not influenced by testosterone replacement therapy.J Endocrinol Invest1996https://conductscience.org/library/papers/8905472PubMed
8866875Cardiovascular responses to static exercise in conscious cats: effects of intracerebroventricular injection of clonidine.J Physiol1996https://conductscience.org/library/papers/8866875PubMed
8853215The role of serotonergic receptors in the effects of mu opioids in squirrel monkeys responding under a titration procedure.Psychopharmacology (Berl)1996https://conductscience.org/library/papers/8853215PubMed

See all 101 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25484

GET https://conductscience.org/api/papers/v1/25484/cited_by?page=2